Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model]

[Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Abstract Text:

    shi-xi liuShi-xi Liu,huan yangHuan Yang,yi-ming yuanYi-ming Yuan,yu-fen guoYu-fen Guo,zhi-quan tangZhi-quan Tang,chuan-yu liangChuan-yu Liang,

    OBJECTIVE: To examine the antitumour efficacy and investigate immunological mechanism of combination therapy of IL-2 gene and IL-12 gene transfer with radiation in an immunocompetent murine model that parallel more closely the clinical therapy of head and neck squamous cell carcinoma (HNSCC). METHODS: Tumors were established in the floor of mouth in C3H/HeJ mice with SCCVII cell line. Lipid-DNA complexed (lipoplexes) by using polycationic liposome-Mediated transduction for HNSCC was transducted in tumor-bearing mouse by direct intratumoral gene transfer. The local tumor was radiated with a dose of 2 Gy in the second day. Tumor sizes were measured before and after the treatment as compared to the different single treatment groups and the controls. After tumors were subculture, the supernatants were collected for IL-2 and IL-12 expression by enzyme-linked immunosobent assay (ELISA). Natural killer (NK) cell activity and cytotoxic T-lymphocyte (CTL) activity were also assayed by LDH methed. CD4+ and CD8+ T-lymphocyte in tumor tissues were examined by immunohistochemistry. RESULTS: HNSCC tumor growth was significantly inhibited following comined IL-2 and IL-12 gene therapy with radiation as compared to IL-2 or IL-12 gene therapy with radiation, single IL-2 or IL-12 gene therapy, radiation alone and the controls. Increased secreted levels of IL-2 and IL-12 protein expression were found in combined and single IL-2 gene or IL-12 gene treated groups. The combination and single gene treated groups produced greater activation of CTL and NK than the controls of all concerned test. The significant CD4+ and CD8+ T lymphocyte infiltration was distributed and the numerous necrosis were seen in tumor tissues after combination therapy. CONCLUSIONS: Combined IL-2 gene and IL-12 gene therapy with radiation could significantly inhibited HNSCC tumor growth in the murine model and efficiently induced antitumor immnunity of the host.

    [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Publishing Authors By Initials

    sx liuSX Liu,h yangH Yang,ym yuanYM Yuan,yf guoYF Guo,zq tangZQ Tang,cy liangCY Liang,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Zhonghua er bi yan hou ke za zhi

    VOLUME: 39

    Page Numbers: 278-82

    Journal Abbreviation: Zhonghua Er Bi Yan Hou Ke Za Z

    ISSN: 0412-3948

    DAY: 1

    MONTH: May

    YEAR: 2004

    [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Information

    Number of References:

    LANGUAGE: chi

    NlmUniqueID: 16210350

    [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model]

    AFFILIATION: Department of Otorhinolaryngology, West China Hospital, Sichuan University, Chengdu 610041, China. liusx@mcwcums.com

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Zhonghua Er Bi Yan Hou Ke Za Z

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News